P. Schmid

1.3k total citations · 1 hit paper
4 papers, 343 citations indexed

About

P. Schmid is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, P. Schmid has authored 4 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Cancer Research. Recurrent topics in P. Schmid's work include Advanced Breast Cancer Therapies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and HER2/EGFR in Cancer Research (2 papers). P. Schmid is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and HER2/EGFR in Cancer Research (2 papers). P. Schmid collaborates with scholars based in United Kingdom, United States and Germany. P. Schmid's co-authors include Hope S. Rugo, Carlos H. Barrios, Leisha A. Emens, Eric P. Winer, Volkmar Henschel, Véronique Dièras, Andreas Schneeweiß, Shilpen Patel, Manika Kaul and Luciana Molinero and has published in prestigious journals such as Annals of Oncology and ESMO Open.

In The Last Decade

P. Schmid

4 papers receiving 336 citations

Hit Papers

First-line atezolizumab plus nab-paclitaxel for unresecta... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Schmid United Kingdom 3 287 142 113 67 49 4 343
A. Swat Switzerland 4 305 1.1× 135 1.0× 112 1.0× 89 1.3× 45 0.9× 6 354
Chelsea Andrews United States 8 289 1.0× 120 0.8× 60 0.5× 70 1.0× 31 0.6× 17 320
M. Nechaeva Russia 8 326 1.1× 164 1.2× 100 0.9× 104 1.6× 57 1.2× 17 401
W Kitonyi Grace Canada 2 233 0.8× 121 0.9× 86 0.8× 95 1.4× 114 2.3× 2 351
M.C. Liu United States 3 418 1.5× 158 1.1× 126 1.1× 159 2.4× 79 1.6× 7 490
Michela Palleschi Italy 9 189 0.7× 133 0.9× 75 0.7× 38 0.6× 75 1.5× 46 281
Mitsugu Yamamoto Japan 7 252 0.9× 88 0.6× 147 1.3× 41 0.6× 68 1.4× 12 336
Elza C. de Bruin United Kingdom 6 171 0.6× 112 0.8× 140 1.2× 43 0.6× 101 2.1× 8 308
Dina Pietrangelo United States 3 311 1.1× 125 0.9× 71 0.6× 124 1.9× 40 0.8× 4 345
Julie Tisserand France 7 191 0.7× 104 0.7× 84 0.7× 75 1.1× 91 1.9× 8 289

Countries citing papers authored by P. Schmid

Since Specialization
Citations

This map shows the geographic impact of P. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schmid more than expected).

Fields of papers citing papers by P. Schmid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schmid. The network helps show where P. Schmid may publish in the future.

Co-authorship network of co-authors of P. Schmid

This figure shows the co-authorship network connecting the top 25 collaborators of P. Schmid. A scholar is included among the top collaborators of P. Schmid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Schmid. P. Schmid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Quintana, Ángela, Kamal S. Saini, Laura Vidal, et al.. (2024). Window of opportunity trials with immune checkpoint inhibitors in triple-negative breast cancer. ESMO Open. 9(10). 103713–103713. 7 indexed citations
2.
O’Shaughnessy, Joyce, P. Schmid, Zhimin Shao, et al.. (2024). 436TiP DYNASTY-Breast02: A phase III trial of BNT323/DB-1303 vs investigator's choice chemotherapy in HER2-low, hormone receptor positive, metastatic breast cancer. Annals of Oncology. 35. S403–S403. 1 indexed citations
4.
Emens, Leisha A., Sylvia Adams, Carlos H. Barrios, et al.. (2021). First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis. Annals of Oncology. 32(8). 983–993. 293 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026